Gonzalez-Ortiz, F., Kirsebom, B., Contador, J., Tanley, J. E., Selnes, P., Gísladóttir, B., . . . Blennow, K. (2024). Plasma brain-derived tau is an amyloid-associated neurodegeneration biomarker in Alzheimer’s disease. Nature Communications, 15(1), . https://doi.org/10.1038/s41467-024-47286-5
Chicago-referens (17:e uppl.)Gonzalez-Ortiz, Fernando, et al. "Plasma Brain-derived Tau Is an Amyloid-associated Neurodegeneration Biomarker in Alzheimer’s Disease." Nature Communications 15, no. 1 (2024). https://doi.org/10.1038/s41467-024-47286-5.
MLA-referens (9:e uppl.)Gonzalez-Ortiz, Fernando, et al. "Plasma Brain-derived Tau Is an Amyloid-associated Neurodegeneration Biomarker in Alzheimer’s Disease." Nature Communications, vol. 15, no. 1, 2024, https://doi.org/10.1038/s41467-024-47286-5.
